FDA PMA

neuromodulator for obesity

PMA Number: P130019 · 2019-02-15

ApplicantReshape Lifesciences, Inc.

Decision Date2019-02-15

PMA NumberP130019

Product CodePIM

Device ClassClass 3

Medical SpecialtyU

Advisory CommitteeGU

Device Summary

neuromodulator for obesity is the device name listed in this FDA 510(k) record. The listed applicant is Reshape Lifesciences, Inc.. It received FDA 510(k) clearance on 2019-02-15. The device is classified under product code PIM. It was reviewed by the GU advisory panel.

Frequently Asked Questions

What is the neuromodulator for obesity?

neuromodulator for obesity is a medical device that received FDA 510(k) clearance on 2019-02-15. The listed applicant is Reshape Lifesciences, Inc..

When did neuromodulator for obesity receive FDA 510(k) clearance?

The clearance date for neuromodulator for obesity can be found in the official FDA records.

Who is the listed applicant for neuromodulator for obesity?

The FDA 510(k) record lists Reshape Lifesciences, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for neuromodulator for obesity?

The FDA product code for neuromodulator for obesity is PIM.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT04745156A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade GliomasNOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.